CM
GWPH

Castleark Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Castleark Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-54,690
Closed -$9.43M – 409
2019
Q2 		$9.43M Buy
+54,690
New +$9.46M 0.36% 93

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Castleark Management's GWPH Position: Q3 2019 in Review

Castleark Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 54,690 shares — an estimated $9.43M sold.

Castleark Management first reported a position in GWPH in Q2 2019 and held it in 1 quarter. The position peaked at $9.43M in Q2 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

  • Castleark Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • Castleark Management sold 54,690 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $9.43M.
  • Castleark Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 1 quarter.
  • Castleark Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $9.43M in Q2 2019.
  • 316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Castleark Management's 13F filing for Q3 2019, filed 15 Nov 2019.